Login / Signup

Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trial.

Fernando G ZampieriGlauco Adrieno WestphalMaria Adelaide Dos SantosSamara P C GomesJackeline O GomesKarina L NegrelliRenato H N SantosLuciana M IshiharaTamiris A MirandaLigia N LaranjeiraNanci ValeisEliana Vieira SantucciVicente Cés de Souza DantasOtávio GebaraDanny M CohnGustavo BucheleMariano JaniszewskiFlávio Geraldo de FreitasFelipe Dal-PizzolAlexandre de Matos SoeiroIsabele Ribeiro BertiAlmir GermanoDaniel Almeida SchettiniRegis G RosaMaicon FalavignaViviane C VeigaLuciano C P AzevedoLucas P DamianiFlávia R MachadoAlexandre B Cavalcantinull null
Published in: Journal of critical care (2024)
NCT04549922.
Keyphrases
  • randomized controlled trial
  • coronavirus disease
  • sars cov
  • study protocol
  • stem cells
  • systematic review
  • clinical trial
  • bone marrow
  • smoking cessation